Access Healthcare for Medical Products (Access Healthcare) provides pharmaceutical companies with innovative marketing and sales solutions in the MENA (Middle East & North Africa) region
J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021
The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
The issue will consist of the issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders
As of FY21, it is the largest independent medical device company and the second-largest company overall, in the surgical consumables market in India with a 7.91 per cent share based on the value
The company has been consistently reducing debt
The first quarter performance reflects growth across all its business divisions as the company continued to operate at normal levels
Revenue from operations for the year ended March 31, 2021 is ?2,239 crore
Subscribe To Our Newsletter & Stay Updated
